Evidence map›Paper›PMID 34872955›Full record

ReviewCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2021

Prevention and management of hyperkalemia in patients treated with renin-angiotensin-aldosterone system inhibitors.

Jordan Weinstein, Louis-Philippe Girard, Serge Lepage, Robert S McKelvie, Karthik Tennankore

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Review
  6. Review
  7. Review
  8. Management of hyperkalemia: Expert consensus from Kuwait - a Modified Delphi Approach.International journal of nephrology and renovascular disease · 2024
    Article
  9. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
    Review
  10. An approach to treating older adults with chronic kidney disease.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review of the top nephrology studies of 2020-2023.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jordan WeinsteinDivision of Nephrology (Weinstein), St. Michael's Hospital, University of Toronto, Toronto, Ont.; Glomerulonephritis Clinic (Girard), University of Calgary, Calgary, Alta.; Sherbrooke University (Lepage), Sherbrooke, Que.; Division of Cardiology (McKelvie), St. Joseph's Health Care; Canada and Western University (McKelvie), London, Ont.; Nova Scotia Health Authority (Tennankore), Dalhousie University, Halifax, NS drjweinstein@gmail.com.
Louis-Philippe GirardDivision of Nephrology (Weinstein), St. Michael's Hospital, University of Toronto, Toronto, Ont.; Glomerulonephritis Clinic (Girard), University of Calgary, Calgary, Alta.; Sherbrooke University (Lepage), Sherbrooke, Que.; Division of Cardiology (McKelvie), St. Joseph's Health Care; Canada and Western University (McKelvie), London, Ont.; Nova Scotia Health Authority (Tennankore), Dalhousie University, Halifax, NS.
Serge LepageDivision of Nephrology (Weinstein), St. Michael's Hospital, University of Toronto, Toronto, Ont.; Glomerulonephritis Clinic (Girard), University of Calgary, Calgary, Alta.; Sherbrooke University (Lepage), Sherbrooke, Que.; Division of Cardiology (McKelvie), St. Joseph's Health Care; Canada and Western University (McKelvie), London, Ont.; Nova Scotia Health Authority (Tennankore), Dalhousie University, Halifax, NS.
Robert S McKelvieDivision of Nephrology (Weinstein), St. Michael's Hospital, University of Toronto, Toronto, Ont.; Glomerulonephritis Clinic (Girard), University of Calgary, Calgary, Alta.; Sherbrooke University (Lepage), Sherbrooke, Que.; Division of Cardiology (McKelvie), St. Joseph's Health Care; Canada and Western University (McKelvie), London, Ont.; Nova Scotia Health Authority (Tennankore), Dalhousie University, Halifax, NS.
Karthik TennankoreDivision of Nephrology (Weinstein), St. Michael's Hospital, University of Toronto, Toronto, Ont.; Glomerulonephritis Clinic (Girard), University of Calgary, Calgary, Alta.; Sherbrooke University (Lepage), Sherbrooke, Que.; Division of Cardiology (McKelvie), St. Joseph's Health Care; Canada and Western University (McKelvie), London, Ont.; Nova Scotia Health Authority (Tennankore), Dalhousie University, Halifax, NS.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiotensin-Converting Enzyme InhibitorsAngiotensin II Type 1 Receptor BlockersHumansHyperkalemiaKidney DiseasesMineralocorticoid Receptor AntagonistsPotassiumRenin-Angiotensin SystemRisk FactorsAngiotensin-Converting Enzyme InhibitorsAngiotensin II Type 1 Receptor BlockersMineralocorticoid Receptor AntagonistsPotassium

Identifiers

PMID34872955
PMCPMC8648362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.